Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) reported Q1 EPS of ($0.80), $0.05 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $31.6 million versus the consensus estimate of $26.07 million.

For earnings history and earnings-related data on Mirum Pharmaceuticals, Inc. (MIRM) click here.